• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

People channel feed

Roger Tsien, 1952-2016: “I’ve al­ways been at­tract­ed to col­ors”

9 years ago

$354M ex­it pack­age in hand, Medi­va­tion CEO David Hung com­pletes a mas­ter class in biotech auc­tions

9 years ago
Pharma

Mar­tin Shkre­li, the ob­scene prankster of biotech, makes his fi­nal ex­it at Kalo­Bios

9 years ago
Pharma

My­lan CEO Bresch hopes to tame the mob with a 50% dis­count for the EpiPen

9 years ago
Pharma

Bind bur­ial com­plete, An­drew Hirsch lands the CFO’s job at high-pro­file Agios

9 years ago
Pharma

Ex-Al­ler­gan CEO David Py­ott backs a biotech start­up along­side Take­da, PhI tri­al set to launch

9 years ago
Startups
R&D

Mar­tin Shkre­li will have his day(s) in court - next June

9 years ago

Ex-Bio­gen ex­ec Steve Holtz­man hears the call of Third Rock’s am­bi­tious Deci­bel

9 years ago
Startups

Ebo­la! Zi­ka! ATM! In­ovio CEO Kim called out for gam­ing pan­dem­ic pan­ic

9 years ago
Pharma

Gary Glick gets $27M to leap back in­to im­muno-on­col­o­gy R&D with No­var­tis, At­las and Abing­worth in his cor­ner

9 years ago
R&D

Sean Park­er finds a big role to play in can­cer R&D: The dis­rup­tive bil­lion­aire

9 years ago
R&D
First page Previous page 9899100101
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times